Inhibition of aflatoxin M1 excretion in rat urine during dietary intervention with oltipraz

Carcinogenesis

Volumn 17, Issue 6, 1996, Pages 1385-1388

  Scholl, Peter ^a   Musser, Steven M ^b   Kensler, Thomas W ^a   Groopman, John D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AFLATOXIN M1; CYTOCHROME P450; ENZYME INHIBITOR; GLUTATHIONE TRANSFERASE; OLTIPRAZ; ANTINEOPLASTIC AGENT; PYRAZINE DERIVATIVE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG MECHANISM; ENZYME INDUCTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; URINARY EXCRETION; ANIMAL; CHEMICALLY INDUCED DISORDER; DIET; DIET THERAPY; DOSE RESPONSE; DRUG DETOXIFICATION; DRUG EFFECT; FISCHER 344 RAT; LIVER; LIVER TUMOR; METABOLISM; URINE;

AFLATOXIN B1; AFLATOXIN M1; ANIMALS; ANTICARCINOGENIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METABOLIC DETOXICATION, DRUG; PYRAZINES; RATS; RATS, INBRED F344;

EID: 0029889347     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.6.1385     Document Type: Article

References (29)

1. 1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis, 7, 1043-1050.
2. 1 in rats. Cancer Lett., 19, 125-132.
3. I-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (Oltipraz): predictive role for short term molecular dosimetry. Cancer Res., 51, 5501-5506.
4. Benson,A.M., Batzinger,R.P., Ou,S.-Y.L., Bueding,E., Cha,Y.-N. and Talalay,P. (1978) Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo[a]pyrene by dietary antioxidants. Cancer Res., 38, 4486-4495.
5. 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res., 46, 3924-3931.
6. 1 hepatocarcinogenesis in the rat. Cancer Res., 47, 5218-5224.
7. Kensler,T.W., Davidson,N.E., Egner,P.A., Guyton,K.Z., Groopman,J.D., Curphey,T.J., Liu,Y.-L. and Roebuck,B.D. (1991) Protection against aflatoxin-induced hepatocarcinogenesis by dithiolethiones. In Bray,G.A. and Ryan,D.H. (eds), Mycotoxins, Cancer and Health. LSU Press, pp. 359-371.
8. 1 in the rat and mouse. Toxicol. Appl. Pharmacol., 90, 401-409.
9. 1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res., 50, 615-620.
10. 1. Pharmacol. Ther., 50, 443-472.
11. 1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors. Biochem. J., 300, 117-124.
12. 7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Carcinogenesis, 13, 101-106.
13. 1 in the rat. Toxicol. Appl. Pharmacol., 93, 442-451.
14. Bolton,M., Muñoz,A., Jacobsen,L., Groopman,J., Maxuitenko,Y., Roebuck,B. and Kensler,T. (1993) Transient intervention with oltipraz protects against aflatoxin induced hepatic tumorigenesis. Cancer Res., 53, 3499-3504.
15. 1 metabolism. FASEB J., 5, A1517.
16. 1 metabolism in human hepatocytes in primary culture. Cancer Res., 55, 5574-5579.
17. 1-4-hydroxylase. J. Biol. Chem., 263, 12187-12189.
18. 1. Cancer Res., 54, 101-108.
19. 1 by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol., 8, 218-225.
20. 1 in rat liver. J. Natl Cancer Inst., 47, 585-592.
21. 1 in rats. Fd Cosmetics Toxicol., 12, 381-184.
22. Scholl,P., Musser,S.M., Kensler,T.W. and Groopman,J.D. (1995) Molecular biomarkers for aflatoxins and their application to human liver cancer. Pharmacogenetics, 5, S171-S176.
23. 7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Cancer Res., 52, 267-274, 1992.
24. Bieder,A., Decouvelaere,B., Gaillard,C. et al. (1983) Comparison of the metabolism of oltipraz in the mouse, rat and monkey and in man. Arzneim. Forsch./Drug Res., 33, 1289-1297.
25. 14C-oltipraz in animals. Arzneim.-Forsch./Drug Res., 35, 1431-1436.
26. Shiraki,H. and Guengerich,F.P. (1984) Turnover of membrane proteins: kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydrolase. Arch. Biochem. Biophys., 235, 86-96.
27. Primiano,T., Egner,P.A., Sutter,T.R., Kelloff,G.J., Roebuck,B.D. and Kensler,T.W. (1995) Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res., 55, 4319-4324.
28. 1 exo- and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol., 5, 470-478.
29. Kensler,T.W. and Helzlsouer,K.J. (1995) Oltipraz: clinical opportunities for chemoprevention. J. Cell Biochem., 22, 101-107.